Report an error

Spotted something inaccurate in “Tildrakizumab Partially Reverses Mortality-Predictive Epigenetic Aging Clocks in Psoriasis Patients Over 52 Weeks”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.